EPIC Code

LAB3233
HSVPCRBLD

Performing Lab

UCHealth University of Colorado Hospital Clinical Laboratory - Molecular Diagnostics

Collect

Preferred: 6 mL Pink (K2 EDTA)
Acceptable: 4 mL Purple (EDTA) or 2.0 mL Pink top (K2EDTA) BD Microtainer
Minimum volume: >0.2 mL whole blood

Specimen Preparation

Do not centrifuge.

Unacceptable Conditions

  • Specimens other than EDTA whole blood.
  • Sample not properly identified, incorrect container, insufficient volume, or past stability.
  • Lab Note: Samples processed in lab using non-sterile technique—including samples previously tested with a “common needle” on an instrument (e.g., Sysmex)—are unacceptable.

Storage/Transport Temperature

Internal: Ambient
Offsite: Refrigerated

Performed

Day shift: Monday–Friday

Stability (from collection to initiation)

Room Temp: 12 hours
Refrigerated: 3 days
Frozen: ≥31 days

Performed

Day shift: Monday–Friday

Methodology

Qualitative Real-time PCR

Reported

1–3 days

Synonyms

  • HSVPCRBLD
  • HSV PCR Whole Blood

EPIC Code

LAB3233
HSVPCRBLD

Reference Interval

HSV Type 1 Not detected
HSV Type 2 Not detected

Note: Separate qualitative results will usually be given for both HSV type 1 and HSV type 2. Occasionally some samples do not exhibit clear typing and these samples will be resulted as "positive - unable to type."

Interpretive Data

Interpretation:
Not detected = Negative, no virus detected.
Detected = Positive, virus detected.

Methodology:
This test employs real-time PCR amplification of a Herpes simplex virus-specific conserved genetic target. A positive result should be coupled with clinical indicators for diagnosis.  A "Not detected" result for this assay does not exclude Herpes simplex virus involvement in a disease process. This test was developed and its performance characteristics determined by the UCH Clinical Laboratory.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is used for clinical purposes.  It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendment of 1988 ("CLIA") as qualified to perform high complexity clinical testing.

CPT Codes

87529 x2
Collection

EPIC Code

LAB3233
HSVPCRBLD

Performing Lab

UCHealth University of Colorado Hospital Clinical Laboratory - Molecular Diagnostics

Collect

Preferred: 6 mL Pink (K2 EDTA)
Acceptable: 4 mL Purple (EDTA) or 2.0 mL Pink top (K2EDTA) BD Microtainer
Minimum volume: >0.2 mL whole blood

Specimen Preparation

Do not centrifuge.

Unacceptable Conditions

  • Specimens other than EDTA whole blood.
  • Sample not properly identified, incorrect container, insufficient volume, or past stability.
  • Lab Note: Samples processed in lab using non-sterile technique—including samples previously tested with a “common needle” on an instrument (e.g., Sysmex)—are unacceptable.

Storage/Transport Temperature

Internal: Ambient
Offsite: Refrigerated

Performed

Day shift: Monday–Friday

Stability (from collection to initiation)

Room Temp: 12 hours
Refrigerated: 3 days
Frozen: ≥31 days

Ordering

Performed

Day shift: Monday–Friday

Methodology

Qualitative Real-time PCR

Reported

1–3 days

Synonyms

  • HSVPCRBLD
  • HSV PCR Whole Blood

EPIC Code

LAB3233
HSVPCRBLD

Result Interpretation

Reference Interval

HSV Type 1 Not detected
HSV Type 2 Not detected

Note: Separate qualitative results will usually be given for both HSV type 1 and HSV type 2. Occasionally some samples do not exhibit clear typing and these samples will be resulted as "positive - unable to type."

Interpretive Data

Interpretation:
Not detected = Negative, no virus detected.
Detected = Positive, virus detected.

Methodology:
This test employs real-time PCR amplification of a Herpes simplex virus-specific conserved genetic target. A positive result should be coupled with clinical indicators for diagnosis.  A "Not detected" result for this assay does not exclude Herpes simplex virus involvement in a disease process. This test was developed and its performance characteristics determined by the UCH Clinical Laboratory.  It has not been cleared or approved by the U.S. Food and Drug Administration.  The FDA has determined that such clearance or approval is not necessary.  This test is used for clinical purposes.  It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendment of 1988 ("CLIA") as qualified to perform high complexity clinical testing.

Administrative

CPT Codes

87529 x2